Becton, Dickinson and Company (BDX) Earnings Call Transcripts

Becton, Dickinson and Company's Latest Earnings Call - Q4 FY2026

Becton, Dickinson and Company (BDX) reported strong results for Q4 and FY 2026, with revenue of $5.3 billion, up 5.6%, and adjusted EPS of $4.15, reflecting a 27.3% increase. For the full year, revenue reached $19.5 billion, a 3.9% increase, with adjusted EPS growing 6.7% to $12.70. Management provided guidance for FY 2027, expecting low single-digit revenue growth, with adjusted EPS projected between $13.10 and $13.30, indicating a cautious outlook due to the Alaris headwind.

Reported metrics

Guidance from management

Management expects low single-digit revenue growth for FY 2027, with adjusted EPS projected between $13.10 and $13.30. This guidance reflects a cautious approach due to the Alaris headwind, which is expected to impact growth in the first half of the fiscal year.

What management said

Thanks, Vitor. Before we open the call for questions, I want to take a moment to recognize our associates around the world. Completing the Life Sciences separation, while simultaneously executing against our new BD strategy, require tremendous focus and commitment across the organization. Our strong finish to fiscal '26 reflects their work, and I want to thank each of our associates for everything you've done. We ent...

Thanks for the question, Vijay. But we are very pleased with how those -- our execution is playing out. And again, as part of our BD excellence strategy, we were really doubled down on commercial excellence in FY '26, right? Whether or not it's our comp plans our hiring approaches, our training approaches, our digital systems, we are seeing benefits of that coming through complemented by physical expansion of more pe...

What analysts pressed on

Analysts expressed concerns regarding the impact of the Alaris headwind on Q1 growth, which is expected to be at the low end of the range. There were questions about the company's guidance philosophy and the potential for conservatism in their forecasts, particularly in light of recent strong performance.

Main topics on the call

• Revenue Growth Acceleration — BDX reported Q4 revenue of $5.3 billion, up 5.6%, with high single-digit growth excluding the Alaris comparison. Management noted, "Growth remained broad-based with momentum across all our businesses," highlighting stron...
• Adjusted EPS Growth — The company achieved adjusted EPS of $4.15, a 27.3% increase year-over-year, which was described as "ahead of our expectations" by management. This reflects strong revenue performance and disciplined execution.
• Strategic Partnership with U.S. Government — BDX announced a landmark partnership with the U.S. government, committing to invest $19 billion in domestic manufacturing, with $3 billion allocated for manufacturing expansion. This partnership aims to enhance supply ch...
• Fiscal Year 2027 Guidance — Management expects low single-digit revenue growth for FY 2027, with adjusted EPS projected between $13.10 and $13.30. Vitor Roque stated, "Excluding the Alaris impact, we expect mid-single-digit growth at the midpoint o...

Read the full Becton, Dickinson and Company transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 84 Becton, Dickinson and Company earnings call transcripts on record, spanning January 14, 2020 to November 5, 2026. Based on this history, Becton, Dickinson and Company reports quarterly. The most recent call on file is dated November 5, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

BDX

Exchange

NYSE

Country

US

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

84

First call

January 14, 2020

Most recent

November 5, 2026

Reporting cadence

quarterly